In addition to CD24 blockade, the recombinant human Siglec-10 Fc chimera decreased anti-inflammatory molecules and considerably increased cytotoxic CD8+ cells by blocking Siglec-10 in hepatocellular carcinoma (HCC)-derived single cells. Here, CD8A is linked to hepatocellular carcinoma.